Pacira BioSciences (PCRX) Restructuring Costs (2023 - 2024)
Pacira BioSciences' Restructuring Costs was $1.2 million in Q3 2024, up 500.0% from $200,000 a year earlier and up 20.0% from the prior quarter.
Pacira BioSciences (PCRX) Restructuring Costs (2023 - 2024) Analysis & Trends
On a trailing twelve-month basis, Pacira BioSciences' Restructuring Costs was $3.34 million through Sep 30, 2024, up 193.7% year-over-year; for FY2017, it was $51.5 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Pacira BioSciences | 1.45 Bn | 466.99 Mn | 139.42 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 936,000.00 |
Pacira BioSciences Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=PCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();